Tokyo Tape
Sign in
← M3

Half-year report · HY

2413.TEDINET S100X3FS
Period2025-04-01 → 2025-09-30
Filed2025-11-14
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥170.9bn2025-04-01 → 2025-09-30Cons.Revenue IFRS
Revenue¥284.9bn2024-04-01 → 2025-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥124.8bn2024-04-01 → 2024-09-30Cons.Revenue IFRS
Operating income¥36.0bn2025-04-01 → 2025-09-30Cons.Operating profit loss IFRS
Operating income¥29.0bn2024-04-01 → 2024-09-30Cons.Operating profit loss IFRS
Profit before tax¥36.7bn2025-04-01 → 2025-09-30Cons.Profit loss before tax IFRS
Profit before tax¥64.8bn2024-04-01 → 2025-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥29.1bn2024-04-01 → 2024-09-30Cons.Profit loss before tax IFRS
Net income (owners)¥22.7bn2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥40.5bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥17.3bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥25.3bn2025-04-01 → 2025-09-30Cons.Profit loss IFRS
Net income¥19.6bn2024-04-01 → 2024-09-30Cons.Profit loss IFRS
Total assets¥612.4bnat 2025-09-30Cons.Assets IFRS
Total assets¥581.7bnat 2025-03-31Cons.Assets IFRS
Total assets¥491.5bnat 2024-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥188.7bnat 2025-09-30Cons.Liabilities IFRS
Total liabilities¥168.9bnat 2025-03-31Cons.Liabilities IFRS
Net assets / equity¥423.7bnat 2025-09-30Cons.Equity IFRS
Net assets / equity¥412.8bnat 2025-03-31Cons.Equity IFRS
Net assets / equity¥364.4bnat 2024-09-30Cons.Equity IFRS
Net assets / equity¥366.7bnat 2024-03-31vCons.Equity IFRS
Equity (owners)¥387.3bnat 2025-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥378.4bnat 2025-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥349.5bnat 2024-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥133.8bnat 2025-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥134.9bnat 2025-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥148.1bnat 2024-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥149.7bnat 2024-03-31vCons.Cash and cash equivalents IFRS
Operating cash flow¥36.3bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥51.7bn2024-04-01 → 2025-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥23.6bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥15.5bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥39.1bn2024-04-01 → 2025-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥11.3bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥22.2bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥27.2bn2024-04-01 → 2025-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥12.6bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥33.472025-04-01 → 2025-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥59.622024-04-01 → 2025-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥25.472024-04-01 → 2024-09-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥33.462025-04-01 → 2025-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥59.62024-04-01 → 2025-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥25.42024-04-01 → 2024-09-30Cons.Diluted earnings loss per share IFRS
Equity ratio63.2%at 2025-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio65.1%at 2025-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio71.1%at 2024-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 57
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2025-04-01 → 2025-09-30−¥2.2bn
Reconciling Itemsreconcilingrevenue intersegment2025-04-01 → 2025-09-30−¥2.2bn
Reconciling Itemsreconcilingsegment profit2025-04-01 → 2025-09-30−¥804m
Career Solutionreportable segmentrevenue2025-04-01 → 2025-09-30¥13.2bn
Career Solutionreportable segmentrevenue external2025-04-01 → 2025-09-30¥13.1bn
Career Solutionreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥38m
Career Solutionreportable segmentsegment profit2025-04-01 → 2025-09-30¥4.3bn
Evidence Solutionreportable segmentrevenue2025-04-01 → 2025-09-30¥12.2bn
Evidence Solutionreportable segmentrevenue external2025-04-01 → 2025-09-30¥12.1bn
Evidence Solutionreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥85m
Evidence Solutionreportable segmentsegment profit2025-04-01 → 2025-09-30¥2.3bn
Medical Platformreportable segmentrevenue2025-04-01 → 2025-09-30¥52.0bn
Medical Platformreportable segmentrevenue external2025-04-01 → 2025-09-30¥49.9bn
Medical Platformreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥2.0bn
Medical Platformreportable segmentsegment profit2025-04-01 → 2025-09-30¥17.9bn
Overseasreportable segmentrevenue2025-04-01 → 2025-09-30¥41.1bn
Overseasreportable segmentrevenue external2025-04-01 → 2025-09-30¥41.1bn
Overseasreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥5m
Overseasreportable segmentsegment profit2025-04-01 → 2025-09-30¥8.9bn
Patient Solutionreportable segmentrevenue2025-04-01 → 2025-09-30¥27.4bn
Patient Solutionreportable segmentrevenue external2025-04-01 → 2025-09-30¥27.4bn
Patient Solutionreportable segmentsegment profit2025-04-01 → 2025-09-30¥1.1bn
Site Solutionreportable segmentrevenue2025-04-01 → 2025-09-30¥26.3bn
Site Solutionreportable segmentrevenue external2025-04-01 → 2025-09-30¥26.3bn
Site Solutionreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥3m
Site Solutionreportable segmentsegment profit2025-04-01 → 2025-09-30¥1.7bn
—segment totalrevenue2025-04-01 → 2025-09-30¥172.0bn
—segment totalrevenue external2025-04-01 → 2025-09-30¥169.9bn
—segment totalrevenue intersegment2025-04-01 → 2025-09-30¥2.2bn
—segment totalsegment profit2025-04-01 → 2025-09-30¥36.2bn
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥1.9bn
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥1.9bn
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥1.7bn
Career Solutionreportable segmentrevenue2024-04-01 → 2024-09-30¥11.6bn
Career Solutionreportable segmentrevenue external2024-04-01 → 2024-09-30¥11.6bn
Career Solutionreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥18m
Career Solutionreportable segmentsegment profit2024-04-01 → 2024-09-30¥4.1bn
Evidence Solutionreportable segmentrevenue2024-04-01 → 2024-09-30¥11.9bn
Evidence Solutionreportable segmentrevenue external2024-04-01 → 2024-09-30¥11.8bn
Evidence Solutionreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥100m
Evidence Solutionreportable segmentsegment profit2024-04-01 → 2024-09-30¥1.9bn
Medical Platformreportable segmentrevenue2024-04-01 → 2024-09-30¥42.5bn
Medical Platformreportable segmentrevenue external2024-04-01 → 2024-09-30¥40.7bn
Medical Platformreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥1.7bn
Medical Platformreportable segmentsegment profit2024-04-01 → 2024-09-30¥14.6bn
Overseasreportable segmentrevenue2024-04-01 → 2024-09-30¥38.0bn
Overseasreportable segmentrevenue external2024-04-01 → 2024-09-30¥38.0bn
Overseasreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥28m
Overseasreportable segmentsegment profit2024-04-01 → 2024-09-30¥6.6bn
Site Solutionreportable segmentrevenue2024-04-01 → 2024-09-30¥21.6bn
Site Solutionreportable segmentrevenue external2024-04-01 → 2024-09-30¥21.6bn
Site Solutionreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥6m
Site Solutionreportable segmentsegment profit2024-04-01 → 2024-09-30¥3.0bn
—segment totalrevenue2024-04-01 → 2024-09-30¥125.6bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥123.7bn
—segment totalrevenue intersegment2024-04-01 → 2024-09-30¥1.9bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥30.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 668
ItemContextValueUnit
Other components of equity IFRSPrior1YearInstant30521000000JPY
Other components of equity IFRSInterimInstant33174000000JPY
Retained earnings IFRSPrior1YearInstant289848000000JPY
Retained earnings IFRSInterimInstant298388000000JPY
Equity attributable to owners of parent IFRSPrior1YearInstant378436000000JPY
Equity attributable to owners of parent IFRSInterimInstant387297000000JPY
Non controlling interests IFRSPrior1YearInstant34363000000JPY
Non controlling interests IFRSInterimInstant36438000000JPY
Equity IFRSPrior1YearInstant412799000000JPY
Equity IFRSInterimInstant423735000000JPY
Liabilities and equity IFRSPrior1YearInstant581741000000JPY
Liabilities and equity IFRSInterimInstant612393000000JPY
Revenue IFRSPrior1InterimDuration124819000000JPY
Revenue IFRSInterimDuration170885000000JPY
Cost of sales IFRSPrior1InterimDuration53918000000JPY
Cost of sales IFRSInterimDuration84894000000JPY
Gross profit IFRSPrior1InterimDuration70901000000JPY
Gross profit IFRSInterimDuration85991000000JPY
Selling general and administrative expenses IFRSPrior1InterimDuration42908000000JPY
Selling general and administrative expenses IFRSInterimDuration52419000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1InterimDuration1308000000JPY
Share of profit loss of investments accounted for using equity method IFRSInterimDuration1579000000JPY
Other income IFRSPrior1InterimDuration251000000JPY
Other income IFRSInterimDuration923000000JPY
Other expenses IFRSPrior1InterimDuration569000000JPY
Other expenses IFRSInterimDuration82000000JPY
Operating profit loss IFRSPrior1InterimDuration28982000000JPY
Operating profit loss IFRSInterimDuration35992000000JPY
Finance income IFRSPrior1InterimDuration1133000000JPY
Finance income IFRSInterimDuration1153000000JPY
Finance costs IFRSPrior1InterimDuration1041000000JPY
Finance costs IFRSInterimDuration463000000JPY
Profit loss before tax IFRSPrior1InterimDuration29074000000JPY
Profit loss before tax IFRSInterimDuration36681000000JPY
Income tax expense IFRSPrior1InterimDuration9485000000JPY
Income tax expense IFRSInterimDuration11361000000JPY
Profit loss IFRSPrior1InterimDuration19589000000JPY
Profit loss IFRSInterimDuration25320000000JPY
Profit loss attributable to owners of parent IFRSPrior1InterimDuration17294000000JPY
Profit loss attributable to owners of parent IFRSInterimDuration22711000000JPY
Profit loss attributable to non controlling interests IFRSPrior1InterimDuration2294000000JPY
Profit loss attributable to non controlling interests IFRSInterimDuration2609000000JPY
Profit loss IFRSPrior1InterimDuration19589000000JPY
Profit loss IFRSInterimDuration25320000000JPY
Basic earnings loss per share IFRSPrior1InterimDuration25.47
Basic earnings loss per share IFRSInterimDuration33.47
Diluted earnings loss per share IFRSPrior1InterimDuration25.40
Diluted earnings loss per share IFRSInterimDuration33.46
Profit loss IFRSPrior1InterimDuration19589000000JPY
Profit loss IFRSInterimDuration25320000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2025-03-31pass
balance sheet identityconsolidated 2025-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass